Search Results

You searched for : Treatmentforasthma

	Lupin receives UK marketing authorization for Luforbec, first branded generic alternative to Fostair for treatment of Asthma & COPD ... Jun 14
	Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma Tezepelumabâ€™s effect on other efficacy parameters was similar to those observed in previous trials, including the registrational Phase III NAVIGATOR trial.... Dec 22
	Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma PONENTE Phase IIIb open-label trial showed Fasenra eliminated the use of maintenance oral corticosteroids in OCS-dependent asthma patients with a broad range of ... Oct 29
	Dupixent reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in childrenâ€™s lung function A pivotal Phase 3 trial of Dupixent met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-... Oct 13
4 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Lupin receives UK marketing authorization for Luforbec, first branded generic alternative to Fostair for treatment of Asthma & COPD

Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma

Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma

Dupixent reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in childrenâ€™s lung function

Trending Now